BABY stock forecast
Our latest prediction for Natus Medical, Inc.'s stock price was made on the Aug. 30, 2018 when the stock price was at 36.80$.
In the short term (2weeks), BABY's stock price should underperform the market by -0.27%. During that period the price should oscillate between -5.25% and +4.73%.
In the medium term (3months), BABY's stock price should underperform the market by -1.52%. During that period the price should oscillate between -13.76% and +13.87%.Get email alerts
About Natus Medical, Inc.
Natus Medical, Inc. engages in the provision of newborn care, neurology, and hearing and balance assessment healthcare products and services. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.
At the moment the company generates 521M USD in revenues.
On its last earning announcement, the company reported a loss of -0.55$ per share.
The book value per share is 12.18$
Three months stock forecastAug. 30, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|